There is a relation between using Androgel and prostate disorders.
Acctually, evaluation of the patient for prostate disorders prior to initiating and during treatment with androgens is appropriate.
Patients with prostate enlargement that are treated with androgens are at an increased risk for worsening of signs and symptoms of BP.
Patients treated with androgens may be at increased risk for prostate cancer.
In some patients, increase of serum PSA (prostate-specific antigen is a protein produced by the cells of the prostate gland and PSA test measures the level of PSA in the blood, prostate cancer, benign prostate enlargement, inflammation, infection, age, and race are different reasons for elevated PSA) is seen after first year of therapy with this gel.